BRCA1-p53 relationship in hereditary breast cancer

International Journal of Oncology

Volumn 10, Issue 2, 1997, Pages 349-353

  Sobol, Hagay ^a   Stoppa Lyonnet, Dominique ^b   Bressac De Paillerets, Brigitte ^c   Peyrat, Jean Philippe ^d   Guinebretiere, Jean Marc ^c   Jacquemier, Jocelyne ^a   Eisinger, François ^a   Birnbaum, Daniel ^a,e  

^a INSTITUT PAOLI CALMETTES   (France)

^b INSTITUT CURIE   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d CENTRE OSCAR LAMBRET   (France)

^e INSERM   (France)

Author keywords

BRCA1; cooperation; hereditary breast cancer; p53; ring finger; tumor suppressor gene

Indexed keywords

ARTICLE; BREAST CANCER; CELL DIFFERENTIATION; CELL PROLIFERATION; EPITHELIUM CELL; FAMILY; GENE EXPRESSION; GENETIC DISORDER; GENETIC TRANSCRIPTION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MUTATION; PRIORITY JOURNAL;

EID: 0031051068     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.10.2.349     Document Type: Article

References (39)

1. Narod S, Ford D, Devilee P, Barkardottir R, Lynch H, Smith S, Ponder B, Weber B, Garber J, Birch J, Cornelis R, Kelsell D, Spurr N, Smyth E, Haites N, Sobol H, Bignon Y, Chang-Claude J, Hamann U, Lindblom A, Borg A, Piver M, Gallion HH, Struewing J, Whitemore A, Tonin P, Goldgar D, Easton D and the Breast Cancer Linkage Consortium: An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Am J Hum Genet 56: 254-264, 1995.
2. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hyssey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrisson P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Albright LC, Goldgar D, Wiseman R, Kamb A and Skolnick MH: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66-71, 1994.
3. Abel KJ, Xu J, Yin GY, Lyons RH, Meisier MH and Weber BL: Mouse Brcal: localization, sequence analysis and identification of evolutionarily conserved domains. Hum Mol Genet 4: 2265-2273, 1995.
4. Sharan S, Wims M and Bradley A: Murine Brcal: sequence and significance for human missense mutations. Hum Mol Genet 4: 2275-2278, 1995.
5. Thompson ME, Jensen RA, Obermiller PS, Page DL and Holt JT: Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nature Genet 9: 444-450, 1995.
6. Marquis ST, Rajan JV, Wynshaw-Boris A, Xu J, Yin G-Y, Abel KJ, Weber BL and Chodosh LA: The developmental pattern of Brcal expression implies a role in differentiation of the breast and other tissues. Nature Genet 11: 17-26, 1995.
7. Gudas JM, Nguyen H, Li T and Cowan KU: Hormone-dependent regulation of BRCA1 in human breast cancer cells. Cancer Res 55: 4561-4565, 1995.
8. Holt J, Thompson ME, Szabo S, Robinson-Benion C, Arteaga CL, King M-C and Jensen RA: Growth retardation and tumor inhibition by BRCA1. Nature Genet 12: 298-302, 1996.
9. Shao N, Chai Y, Shyam E, Reddy P and Rao V: Induction of apoptosis by the tumor suppressor protein BRCA1. Oncogene 13: 1-7, 1996.
10. Jensen R, Thompson ME, Jetton TL, Szabo CI, van der Meer R, Helou B, Tronick SR, Page DL, King M-C and Holt JT: BRCA1 is secreted and exhibits properties of granin. Nature Genet 12: 303-308, 1996.
11. Wilson C, Payton M, Pekar S, Zhang K, Pacifici R, Gudas J, Thukral S, Calzone F, Reese D and Slamon D: BRCA1 protein products: antibody spceficity. Nature Genet 13: 264-265, 1996.
12. Koonin E, Altschul S and Bork P: BRCA1 protein products: functional motifs. Nature Genet 13: 266-267, 1996.
13. Diamandis E: BRCA1 protein products: and secreted tumour suppressors. Nature Genet 13: 268, 1996.
14. Iwabachi K, Bartel P, Li B, Marraccino R and Fields S: Two cellular proteins that bind to wild-type but not mutant p53. Proc Natl Acad Sci USA 91: 6098-6102, 1994.
15. Chapman M and Verma I: Transcriptional activation by BRCA1. Nature 382: 678-679, 1996.
16. Chen Y, Chen C, Riley D, Allred R, Chen P, von Hoff D, Osborne C and Lee W: Aberrant subcellular localization of BRCA1 in breast cancer. Science 270: 789-791, 1995.
17. Chen Y, Farmer A, Chen C, Jones D, Chen P and Lee W-L: BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner. Cancer Res 56: 3168-3172, 1996.
18. Scully R, Ganesan S, Brown M, De Caprio J, Cannistra S, Feunteun J, Schnitt S and Livingston D: Location of BRCA1 in human breast and ovarian cancer cells. Science 272: 123-126, 1996.
19. Sobol H, Mazoyer S, Narod S, Smith S, Black D, Kerbrat P, Jamot B, Solomon E, Ponder B and Guerin D: Genetic heterogeneity of early onset familial breast cancer. Hum Genet 89: 381-383, 1992.
20. Easton DF, Bishop DT, Ford D, Crockford GP and the Breast Cancer Linkage Consortium: Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 52: 678-701, 1993.
21. Mazoyer S, Lalle P, Narod SA, Bignon Y-J, Courjal F, Jamot B, Dutrillaux B, Stoppa-Lyonnet D and Sobol H: Linkage analysis of 19 French breast cancer families, with five chromosome 17q markers. Am J Hum Genet 52: 754-760, 1993.
22. Gayther SA, Warren W, Mazoyer S, Russell PA, Harrington PA, Chiano M, Seal S, Hamoudi R, van Rensburg EJ, Dunning AM, Love R, Evans G, Easton D, Clayton D, Stratton MR and Ponder BAJ: Germline mutations of the DRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nature Genet 11: 428-433, 1995.
23. Eisinger F, Stoppa-Lyonnet D, Longy M, Kerangueven F, Noguchi T, Bailly C, Vincent-Salamon A, Jacquemier J, Birnbaum D and Sobol H: Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer. Cancer Res 56: 471-474, 1996.
24. Stoppa-Lyonnet D, Fricker J, Essioux L, Pages S, Limacher J, Sobol H, Laurent-Puig P and Thomas G: Segregation of two BRCA1 mutations in a single family. Am J Hum Genet 59: 479-481, 1996.
25. Couch F, Weber B and the Breast Cancer Information and Core: Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Hum Mutat 8: 8-18, 1996.
26. Durocher F, Schattuck-Eidens D, McClure M, Labrie F, Skolnick M, Goldgar D and Simard J: Comparison of BRCA1 polymorphisms, rae sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations. Hum Mol Genet 5: 835-842, 1996.
27. Collins FS: Lots of mutations, lots of dilemmas. N Engl J Med 334: 186-188, 1996.
28. Sobol H, Stoppa-Lyonnet D, Bressac-de-Paillerets B, Peyrat JP, Kerangueven F, Janin N, Noguchi T, Eisinger F, Guinebretière JM, Jacquemier J and Birnbaum D: Truncation at conserved terminal regions of BRCA1 protein is associated with highly proliferating hereditary breast cancers. Cancer Res 56: 3216-3219, 1996.
29. Jacquemier J, Moles J, Penault-Llorca F, Adelaide J, Torrente M, Viens P, Birnbaum D and Theillet C: p53 immunohistochemical analysis in breast cancer with four monoclonal antibodies: comparison of staining and PCR-SSCP results. Br J Cancer 69: 846-852, 1994.
30. Penault-Llorca F, Adelaide J, Houvenaeghel G, Hassoun J, Birnbaum D and Jacquemier J: Optimization of immunohistochemical detection of ERBB2 in human breast cancer: impact of fixation. J Pathol 173: 65-75, 1994.
31. Barbareschi M: Prognostic value of the immunohistochemical expression of p53 in breast carcinomas. A review of the literature involving over 9,000 patients. Appl Immunohistochem 4: 106-116, 1996.
32. Malkin D, Li F, Strong L, Fraumeni J, Nelson C, Kim D, Kassel J, Gryka M, Bishoff F, Tainsky M and Friend S: Germ-line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250: 1233-1238, 1990.
33. Barnes D, Hanby A, Gillett C, Mohaned S, Hodgson L, Leigh I, Purkis T, MacGeoch C, Spurr N, Bartek J, Vjtesek B, Picksley S and Lane D: Abnormal expression of wild-type p53 protein in normal cells of a cancer family patient. Lancet 340: 259-263, 1992.
34. Vaughn J, Davis P, Jarboe M, Huper G, Evans A, Wiseman R, Berchuck A, Igelhart J, Futreal A and Marks J: BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells. Cell Growth Differ 7: 711-715, 1996.
35. Hakem R, de la Pompa J, Sirard C, Mo R, Woo M, Hakem A, Wakeman A, Potter J, Reitmair A, Billia F, Firpo E, Hui C, Roberts J, Rossant J and Mak T: The tumor suppressor gene BRCA1 is required for embryonic cellular proliferation in the mouse. Cell 85: 1009-1023, 1996.
36. Gudas J, Li T, Nguyen H, Jensen D, Rauscher F III and Cowan K: Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells. Cell Growth Differ 7: 717-723, 1996.
37. Saurin A, Borden L, Boddy M and Freemont P: Does this have a familiar ring ? Trends Biochem Sci 21: 208-214, 1996.
38. Bienstock R, Darden T, Wiseman R, Pedersen L and Barrett J: Molecular modeling of the amino-terminal zinc finger domain of BRCA1. Cancer Res 56: 2539-2545, 1996.
39. Thor A, Moere D II, Edgerton S, Kawasaki E, Reihsaus E, Lynch H, Marcus J, Schwartz L, Chen L, Mayall B and Smith H: Accumulation of p53 suppressor protein: an independent marker of prognosis in breast cancers. J Natl Cancer Inst 84: 845-855, 1992.